NVO CapEx to Revenue

Novo Nordisk A/S Common Stock · CapEx to Revenue

NVO logo

NVO CapEx to Revenue

Current (TTM)25.53%
NVO CapEx/Revenue (0.00% → 25.53%)
High-resolution chart · PNG

NVO capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
29.1567%
17.6682%
16.7467%
8.3372%
5.245%
17.394%
9.2042%
11.0971%
7.7424%
7.3958%
5.9355%
4.8814%
4.3603%
4.642%
5.0222%
6.4121%
6.0006%
4.4746%
5.799%
8.5593%
11.5557%
10.8128%
9.4423%
15.7006%
16.5903%
11.368%
9.2128%
11.9417%
15.3679%
13.741%
10.9198%
12.852%
18.2518%
18.293%
13.7348%
14.0589%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.